VolitionRx Limited awarded $1.5 million in non-dilutive fund

VolitionRx Limited awarded $1.5 million in non-dilutive funding

VolitionRx (NYSE-A:VNRX) Limited revealed that it has been awarded a further $1.5 million in non-dilutive funding from Namur Invest Capital Risk in Belgium....

Related Keywords

Walloon Region , Waals Gewest , Belgium , United States , United Kingdom , Texas , Gaetan Michel , Renaud Hattiez , Namur Invest Capital Risk , Namur Invest , Key Opinion Leaders ,

© 2025 Vimarsana